Methodology

All entries for: Leukogene Therapeutics Inc.

October 17, 2025

Leukogene Therapeutics Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of acute myelogenous leukemia

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top